Skip to main content
Back
Watch Compare

Agape ATP Corp

Data quality: 100%
ATPC
Nasdaq Services Health Services
$2.69
▼ $0.02 (-0.74%)
Mkt Cap: 2.71 M
Price
$2.71
Mkt Cap
2.71 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -21.33% annually over 5 years
Negative free cash flow of -2.85 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.76%

Growth

Revenue Growth (5Y)
-21.33%
Below sector avg (3.99%)
Revenue (1Y)-7.57%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-11.72%
Above sector avg (-15.95%)
ROIC-9.55%
Net Margin-182.59%
Op. Margin-189.02%

Safety

Debt / Equity
N/A
Current Ratio16.21
Interest CoverageN/A

Valuation

PE (TTM)
-1.00
Above sector avg (-1.17)
P/B Ratio0.12
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -1.0 -1.2
P/B 0.1 1.4
ROE % -11.7 -16.0
Net Margin % -182.6 -19.4
Rev Growth 5Y % -21.3 4.0
D/E — 0.4

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

All Fundamental Metrics
Growth
Revenue Growth (1Y) -7.57% Revenue Growth (3Y) -15.59%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -21.33% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.48 M Net Income (TTM) -2.71 M
ROE -11.72% ROA -11.04%
Gross Margin 52.68% Operating Margin -189.02%
Net Margin -182.59% Free Cash Flow (TTM) -2.85 M
ROIC -9.55% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 16.21
Interest Coverage N/A Asset Turnover 0.06
Working Capital 22.59 M Tangible Book Value 22.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.00 Forward P/E N/A
P/B Ratio 0.12 P/S Ratio 1.83
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -105.12%
Market Cap 2.71 M Enterprise Value 2.58 M
Per Share
EPS (Diluted TTM) -0.25 Revenue / Share 1.48
FCF / Share -2.85 OCF / Share -2.85
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 105.13%
SBC-Adj. FCF N/A Growth Momentum 13.76

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 1.32 M 1.43 M 1.86 M 1.02 M 3.45 M
Net Income -2.47 M -2.10 M -1.69 M -2.52 M 354,766.0
EPS (Diluted) -0.63 -0.03 — — —
Gross Profit 759,148.0 936,572.0 1.19 M 719,629.0 2.68 M
Operating Income -2.57 M -2.15 M -1.53 M -1.86 M -158,135.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — 1,505.0
Interest Expense — — — — —
Income Tax 4,934.0 3,575.0 -4,055.0 137,067.0 161,581.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3.24 M 5.74 M 2.79 M 4.72 M 7.21 M
Total Liabilities 1.31 M 1.36 M 1.23 M 1.41 M 1.29 M
Shareholders' Equity 1.93 M 4.37 M 1.54 M 3.31 M 5.92 M
Total Debt — — — — —
Cash & Equivalents 2.04 M 4.83 M 1.44 M 2.60 M 3.52 M
Current Assets 2.78 M 5.19 M 2.03 M 3.91 M 5.68 M
Current Liabilities 1.12 M 1.07 M 1.23 M 1.31 M 1.04 M